{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:03:36Z","timestamp":1793120616418,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.2119\/molmed.2015.00087","type":"journal-article","created":{"date-parts":[[2015,10,27]],"date-time":"2015-10-27T21:20:22Z","timestamp":1445980822000},"page":"S6-S12","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":327,"title":["High Mobility Group Box Protein 1 (HMGB1): The Prototypical Endogenous Danger Molecule"],"prefix":"10.1186","volume":"21","author":[{"given":"Huan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haichao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangeeta S.","family":"Chavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,27]]},"reference":[{"key":"21010006_CR1","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1016\/0016-5085(95)90765-3","volume":"109","author":"Y Mimura","year":"1995","unstructured":"Mimura Y, Sakisaka S, Harada M, Sata M, Tanikawa K. (1995) Role of hepatocytes in direct clearance of lipopolysaccharide in rats. Gastroenterology. 109:1969\u201376.","journal-title":"Gastroenterology"},{"key":"21010006_CR2","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1126\/science.285.5425.248","volume":"285","author":"H Wang","year":"1999","unstructured":"Wang H, et al. (1999) HMG-1 as a late mediator of endotoxin lethality in mice. Science. 285:248\u2013251.","journal-title":"Science"},{"key":"21010006_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1084\/jem.20141318","volume":"212","author":"H Yang","year":"2015","unstructured":"Yang H, et al. (2015) MD-2 is required for disulfide HMGB1-dependent TLR4 signaling. J. Exp. Med. 212:5\u201314.","journal-title":"J. Exp. Med."},{"key":"21010006_CR4","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1146\/annurev-immunol-030409-101323","volume":"29","author":"U Andersson","year":"2011","unstructured":"Andersson U, Tracey KJ. (2011) HMGB1 is a therapeutic target for sterile inflammation and infection. Annu. Rev. Immunol. 29:139\u201362.","journal-title":"Annu. Rev. Immunol."},{"key":"21010006_CR5","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1084\/jem.192.4.565","volume":"192","author":"U Andersson","year":"2000","unstructured":"Andersson U, et al. (2000) High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J. Exp. Med. 192:565\u201370.","journal-title":"J. Exp. Med."},{"key":"21010006_CR6","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1084\/jem.20052203","volume":"203","author":"S Qin","year":"2006","unstructured":"Qin S, et al. (2006) Role of HMGB1 in apoptosis-mediated sepsis lethality. J. Exp. Med. 203:1637\u201342.","journal-title":"J. Exp. Med."},{"key":"21010006_CR7","doi-asserted-by":"publisher","first-page":"21052","DOI":"10.1073\/pnas.1216195109","volume":"109","author":"C Ye","year":"2012","unstructured":"Ye C, et al. (2012) Human macrophage and dendritic cell-specific silencing of high-mobility group protein B1 ameliorates sepsis in a humanized mouse model. Proc. Natl. Acad. Sci. U. S. A. 109:21052\u20137.","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"21010006_CR8","doi-asserted-by":"crossref","first-page":"930","DOI":"10.2119\/molmed.2012.00195","volume":"18","author":"SS Chavan","year":"2012","unstructured":"Chavan SS, et al. (2012) HMGB1 mediates cognitive impairment in sepsis survivors. Mol. Med. 18:930\u20137.","journal-title":"Mol. Med."},{"key":"21010006_CR9","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/ni1457","volume":"8","author":"J Tian","year":"2007","unstructured":"Tian J, et al. (2007) Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat. Immunol. 8:487\u201396.","journal-title":"Nat. Immunol."},{"key":"21010006_CR10","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature08512","volume":"462","author":"H Yanai","year":"2009","unstructured":"Yanai H, et al. (2009) HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses. Nature. 462:99\u2013103.","journal-title":"Nature"},{"key":"21010006_CR11","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1038\/cdd.2014.40","volume":"21","author":"J Xu","year":"2014","unstructured":"Xu J, et al. (2014) Macrophage endocytosis of high-mobility group box 1 triggers pyroptosis. Cell Death Differ. 21:1229\u201339.","journal-title":"Cell Death Differ."},{"key":"21010006_CR12","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1146\/annurev.iy.12.040194.005015","volume":"12","author":"P Matzinger","year":"1994","unstructured":"Matzinger P. (1994) Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12:991\u20131045.","journal-title":"Annu. Rev. Immunol."},{"key":"21010006_CR13","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nature00858","volume":"418","author":"P Scaffidi","year":"2002","unstructured":"Scaffidi P, Misteli T, Bianchi ME. (2002) Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature. 418:191\u20135.","journal-title":"Nature"},{"key":"21010006_CR14","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1016\/S0140-6736(99)02658-6","volume":"354","author":"M Ombrellino","year":"1999","unstructured":"Ombrellino M, et al. (1999) Increased serum concentrations S12 of high-mobility-group protein 1 in haemorrhagic shock. Lancet. 354:1446\u20137.","journal-title":"Lancet"},{"key":"21010006_CR15","doi-asserted-by":"publisher","first-page":"4931","DOI":"10.4049\/jimmunol.1402490","volume":"194","author":"CP Sodhi","year":"2015","unstructured":"Sodhi CP, et al. (2015) Intestinal epithelial TLR-4 activation is required for the development of acute lung injury after trauma\/hemorrhagic shock via the release of HMGB1 from the gut. J. Immunol. 194:4931\u20139.","journal-title":"J. Immunol."},{"key":"21010006_CR16","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1097\/01.shk.0000209540.99176.72","volume":"25","author":"RS Goldstein","year":"2006","unstructured":"Goldstein RS, et al. (2006) Elevated high-mobility group box 1 levels in patients with cerebral and myocardial ischemia. Shock. 25:571\u20134.","journal-title":"Shock"},{"key":"21010006_CR17","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1084\/jem.20042614","volume":"201","author":"A Tsung","year":"2005","unstructured":"Tsung A, et al. (2005) The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J. Exp. Med. 201:1135\u201343.","journal-title":"J. Exp. Med."},{"key":"21010006_CR18","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1002\/art.11161","volume":"48","author":"R Kokkola","year":"2003","unstructured":"Kokkola R, et al. (2003) Successful treatment of collagen-induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity. Arthritis Rheum. 48:2052\u20138.","journal-title":"Arthritis Rheum."},{"key":"21010006_CR19","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1002\/art.27590","volume":"62","author":"T Ostberg","year":"2010","unstructured":"Ostberg T, et al. (2010) Protective targeting of high mobility group box chromosomal protein 1 in a spontaneous arthritis model. Arthritis Rheum. 62:2963\u201372.","journal-title":"Arthritis Rheum."},{"key":"21010006_CR20","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.bbagrm.2009.09.008","volume":"1799","author":"M Stros","year":"2010","unstructured":"Stros M. (2010) HMGB proteins: interactions with DNA and chromatin. Biochim. Biophys. Acta. 1799:101\u201313.","journal-title":"Biochim. Biophys. Acta."},{"key":"21010006_CR21","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/BF03402105","volume":"9","author":"J Li","year":"2003","unstructured":"Li J, et al. (2003) Structural basis for the proinflammatory cytokine activity of high mobility group box 1. Mol. Med. 9:37\u201345.","journal-title":"Mol. Med."},{"key":"21010006_CR22","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1073\/pnas.2434651100","volume":"101","author":"H Yang","year":"2004","unstructured":"Yang H, et al. (2004) Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc. Natl. Acad. Sci. U. S. A. 101:296\u2013301.","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"21010006_CR23","doi-asserted-by":"publisher","first-page":"250","DOI":"10.2119\/molmed.2011.00389","volume":"18","author":"H Yang","year":"2012","unstructured":"Yang H, et al. (2012) Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1). Mol. Med. 18:250\u20139.","journal-title":"Mol. Med."},{"key":"21010006_CR24","doi-asserted-by":"publisher","first-page":"11942","DOI":"10.1073\/pnas.1003893107","volume":"107","author":"H Yang","year":"2010","unstructured":"Yang H, et al. (2010) A critical cysteine is required for HMGB1 binding to toll-like receptor 4 and activation of macrophage cytokine release. Proc. Natl. Acad. Sci. U. S. A. 107:11942\u20137.","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"21010006_CR25","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1084\/jem.20120189","volume":"209","author":"E Venereau","year":"2012","unstructured":"Venereau E, et al. (2012) Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release. J. Exp. Med. 209:1519\u201328.","journal-title":"J. Exp. Med."},{"key":"21010006_CR26","doi-asserted-by":"publisher","first-page":"3068","DOI":"10.1073\/pnas.1316925111","volume":"111","author":"B Lu","year":"2014","unstructured":"Lu B, et al. (2014) JAK\/STAT1 signaling promotes HMGB1 hyperacetylation and nuclear translocation. Proc. Natl. Acad. Sci. U. S. A. 111:3068\u201373.","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"21010006_CR27","doi-asserted-by":"publisher","first-page":"4385","DOI":"10.4049\/jimmunol.1000803","volume":"185","author":"M Lamkanfi","year":"2010","unstructured":"Lamkanfi M, et al. (2010) Inflammasome-dependent release of the alarmin HMGB1 in endotoxemia. J. Immunol. 185:4385\u201392.","journal-title":"J. Immunol."},{"key":"21010006_CR28","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/nature11290","volume":"488","author":"B Lu","year":"2012","unstructured":"Lu B, et al. (2012) Novel role of PKR in inflamma-some activation and HMGB1 release. Nature. 488:670\u20134.","journal-title":"Nature"},{"key":"21010006_CR29","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1093\/embo-reports\/kvf198","volume":"3","author":"S Gardella","year":"2002","unstructured":"Gardella S, et al. (2002) The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Rep. 3:995\u20131001.","journal-title":"EMBO Rep."},{"key":"21010006_CR30","doi-asserted-by":"publisher","first-page":"350","DOI":"10.2119\/molmed.2013.00117","volume":"20","author":"B Lu","year":"2014","unstructured":"Lu B, et al. (2014) Alpha7 nicotinic acetylcholine receptor signaling inhibits inflammasome activation by preventing mitochondrial DNA release. Mol. Med. 20:350\u20138.","journal-title":"Mol. Med."},{"key":"21010006_CR31","doi-asserted-by":"publisher","first-page":"20699","DOI":"10.1073\/pnas.1320808110","volume":"110","author":"H Yanai","year":"2013","unstructured":"Yanai H, et al. (2013) Conditional ablation of HMGB1 in mice reveals its protective function against endotoxemia and bacterial infection. Proc. Natl. Acad. Sci. U. S. A. 110:20699\u2013704.","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"21010006_CR32","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1126\/science.1168988","volume":"323","author":"GY Chen","year":"2009","unstructured":"Chen GY, Tang J, Zheng P, Liu Y. (2009) CD24 and Siglec-10 selectively repress tissue damage-induced immune responses. Science. 323:1722\u20135.","journal-title":"Science"},{"key":"21010006_CR33","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1083\/jcb.152.6.1197","volume":"152","author":"B Degryse","year":"2001","unstructured":"Degryse B, et al. (2001) The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells. J. Cell Biol. 152:1197\u2013206.","journal-title":"J. Cell Biol."},{"key":"21010006_CR34","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1038\/sj.emboj.7601552","volume":"26","author":"VV Orlova","year":"2007","unstructured":"Orlova VV, et al. (2007) A novel pathway of HMGB1-mediated inflammatory cell recruitment that requires Mac-1-integrin. EMBO J. 26:1129\u201339.","journal-title":"EMBO J."},{"key":"21010006_CR35","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/ni.2376","volume":"13","author":"S Chiba","year":"2012","unstructured":"Chiba S, et al. (2012) Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1. Nat. Immunol. 13:832\u201342.","journal-title":"Nat. Immunol."},{"key":"21010006_CR36","doi-asserted-by":"publisher","first-page":"R136","DOI":"10.1186\/ar3450","volume":"13","author":"H Wahamaa","year":"2011","unstructured":"Wahamaa H, et al. (2011) High mobility group box protein 1 in complex with lipopolysaccharide or IL-1 promotes an increased inflammatory phenotype in synovial fibroblasts. Arthritis Res. Ther. 13:R136.","journal-title":"Arthritis Res. Ther."},{"key":"21010006_CR37","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.4049\/jimmunol.180.4.2531","volume":"180","author":"Y Sha","year":"2008","unstructured":"Sha Y, Zmijewski J, Xu Z, Abraham E. (2008) HMGB1 develops enhanced proinflammatory activity by binding to cytokines. J. Immunol. 180:2531\u20137.","journal-title":"J. Immunol."},{"key":"21010006_CR38","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1111\/jth.12710","volume":"12","author":"N Maugeri","year":"2014","unstructured":"Maugeri N, et al. (2014) Activated platelets present high mobility group box 1 to neutrophils, inducing autophagy and promoting the extrusion of neutrophil extracellular traps. J. Thromb. Haemost. 12:2074\u201388.","journal-title":"J. Thromb. Haemost."},{"key":"21010006_CR39","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1089\/ars.2013.5349","volume":"21","author":"S Balosso","year":"2014","unstructured":"Balosso S, Liu J, Bianchi ME, Vezzani A. (2014) Disulfide-containing high mobility group box-1 promotes N-methyl-D-aspartate receptor function and excitotoxicity by activating Toll-like receptor 4-dependent signaling in hippocampal neurons. Antioxid. Redox. Signal 21:1726\u201340.","journal-title":"Antioxid. Redox. Signal"},{"key":"21010006_CR40","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1189\/jlb.1212662","volume":"93","author":"H Yang","year":"2013","unstructured":"Yang H, Antoine DJ, Andersson U, Tracey KJ. (2013) The many faces of HMGB1: molecular structure-functional activity in inflammation, apoptosis, and chemotaxis. J. Leukoc. Biol. 93:865\u201373.","journal-title":"J. Leukoc. Biol."},{"key":"21010006_CR41","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1189\/jlb.0908548","volume":"86","author":"HS Hreggvidsdottir","year":"2009","unstructured":"Hreggvidsdottir HS, et al. (2009) The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation. J. Leukoc. Biol. 86:655\u201362.","journal-title":"J. Leukoc. Biol."},{"key":"21010006_CR42","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1084\/jem.20081165","volume":"205","author":"V Urbonaviciute","year":"2008","unstructured":"Urbonaviciute V, et al. (2008) Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE. J. Exp. Med. 205:3007\u201318.","journal-title":"J. Exp. Med."},{"key":"21010006_CR43","doi-asserted-by":"publisher","first-page":"19919","DOI":"10.1074\/jbc.274.28.19919","volume":"274","author":"HJ Huttunen","year":"1999","unstructured":"Huttunen HJ, Fages C, Rauvala H. (1999) Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J. Biol. Chem. 274:19919\u201324.","journal-title":"J. Biol. Chem."},{"key":"21010006_CR44","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/978-1-62703-230-8_15","volume":"963","author":"A Rouhiainen","year":"2013","unstructured":"Rouhiainen A, Kuja-Panula J, Tumova S, Rauvala H. (2013) RAGE-mediated cell signaling. Methods Mol. Biol. 963:239\u201363.","journal-title":"Methods Mol. Biol."},{"key":"21010006_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.0300-9475.2005.01534.x","volume":"61","author":"R Kokkola","year":"2005","unstructured":"Kokkola R, et al. (2005) RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages. Scand. J. Immunol. 61:1\u20139.","journal-title":"Scand. J. Immunol."},{"key":"21010006_CR46","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1146\/annurev.immunol.021908.132603","volume":"28","author":"GP Sims","year":"2010","unstructured":"Sims GP, Rowe DC, Rietdijk ST, Herbst R, Coyle AJ. (2010) HMGB1 and RAGE in inflammation and cancer. Annu. Rev. Immunol. 28:367\u201388.","journal-title":"Annu. Rev. Immunol."},{"key":"21010006_CR47","doi-asserted-by":"publisher","first-page":"6244","DOI":"10.4049\/jimmunol.0900390","volume":"183","author":"YH Qin","year":"2009","unstructured":"Qin YH, et al. (2009) HMGB1 enhances the proinflammatory activity of lipopolysaccharide by promoting the phosphorylation of MAPK p38 through receptor for advanced glycation end products. J. Immunol. 183:6244\u201350.","journal-title":"J. Immunol."},{"key":"21010006_CR48","doi-asserted-by":"publisher","first-page":"7777","DOI":"10.1074\/jbc.M113.541474","volume":"289","author":"PM LeBlanc","year":"2014","unstructured":"LeBlanc PM, et al. (2014) An immunogenic peptide in the A-box of HMGB1 protein reverses apoptosis-induced tolerance through RAGE receptor. J. Biol. Chem. 289:7777\u201386.","journal-title":"J. Biol. Chem."},{"issue":"10","key":"21010006_CR49","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1164\/ajrccm.164.10.2106117","volume":"164","author":"H Wang","year":"2001","unstructured":"Wang H, Yang H, Czura CJ, Sama AE, Tracey KJ. (2001) HMGB1 as a late mediator of lethal systemic inflammation. Am. J. Respir. Crit. Care Med. 164(10 Pt 1):1768\u201373.","journal-title":"Am. J. Respir. Crit. Care Med."}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.2119\/molmed.2015.00087.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.2119\/molmed.2015.00087\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.crossref.org\/molmed.2015.00087","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.2119\/molmed.2015.00087.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,6]],"date-time":"2019-04-06T01:23:57Z","timestamp":1554513837000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.2119\/molmed.2015.00087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":49,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["21010006"],"URL":"https:\/\/doi.org\/10.2119\/molmed.2015.00087","relation":{},"ISSN":["1076-1551","1528-3658"],"issn-type":[{"value":"1076-1551","type":"print"},{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"13 April 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}